Butidrine

Butidrine
Names
	IUPAC name 2-(Butan-2-ylamino)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)ethanol
	Other names Butedrine; Butydrine; Hydrobutamine; Idrobutamine
Identifiers
CAS Number	7433-10-5;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL358930;
ChemSpider	14445;
PubChem CID	15177;
CompTox Dashboard (EPA)	DTXSID40864062 ;
	InChI InChI=1S/C16H25NO/c1-3-12(2)17-11-16(18)15-9-8-13-6-4-5-7-14(13)10-15/h8-10,12,16-18H,3-7,11H2,1-2H3 Key: GVNYSERWAKVROD-UHFFFAOYSA-N; InChI=1/C16H25NO/c1-3-12(2)17-11-16(18)15-9-8-13-6-4-5-7-14(13)10-15/h8-10,12,16-18H,3-7,11H2,1-2H3 Key: GVNYSERWAKVROD-UHFFFAOYAF;
	SMILES CCC(C)NCC(C1=CC2=C(CCCC2)C=C1)O;
Properties
Chemical formula	C16H25NO
Molar mass	247.382 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Butidrine (INN) (brand names Betabloc, Butidrate, Recetan), or butedrine or butydrine, also known as hydrobutamine or idrobutamine, is a beta blocker related to pronethalol^[1] and propranolol^[2] that was developed in the 1960s.^[3]^[4] Similarly to certain other beta blockers, butidrine also possesses local anesthetic properties.^[5]

References

^ James A. Bristol (1986). Cardiovascular drugs. John Wiley & Sons, Incorporated. p. 111. ISBN 978-0-471-09228-5.
^ Drug Metabolism Reviews. Marcel Dekker. 1972.
^ I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 58–. ISBN 978-94-011-4439-1.
^ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 197–. ISBN 978-1-4757-2085-3.
^ Robert Charlier (1971). Antianginal drugs: pathophysiological, haemodynamic, methodological, pharmacological, biochemical and clinical basis for their use in human therapeutics. Springer-Verlag. ISBN 978-3-540-05365-1.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

[Bristol1986-1] James A. Bristol (1986). Cardiovascular drugs. John Wiley & Sons, Incorporated. p. 111. ISBN 978-0-471-09228-5.

[2] Drug Metabolism Reviews. Marcel Dekker. 1972.

[MortonHall2012-3] I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 58–. ISBN 978-94-011-4439-1.

[Elks2014-4] J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 197–. ISBN 978-1-4757-2085-3.

[Charlier1971-5] Robert Charlier (1971). Antianginal drugs: pathophysiological, haemodynamic, methodological, pharmacological, biochemical and clinical basis for their use in human therapeutics. Springer-Verlag. ISBN 978-3-540-05365-1.

[1]

[2]

[3]

[4]

[5]